NeoClone (Antibody Reagents Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

NeoClone (Antibody Reagents Business) General Information

Description

Developer of antibody reagent products based in Wisconsin. The company focuses on developing high quality antibody reagents against e coli rna polymerase, yeast rna polymerase, human transcription proteins, cancer markers and neurological injury biomarkers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • WI
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Acquirer
BioLegend
Vertical(s)
Life Sciences
Corporate Office
  • WI
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeoClone (Antibody Reagents Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NeoClone (Antibody Reagents Business)‘s full profile, request access.

Request a free trial

NeoClone (Antibody Reagents Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NeoClone (Antibody Reagents Business)‘s full profile, request access.

Request a free trial

NeoClone (Antibody Reagents Business) FAQs

  • Where is NeoClone (Antibody Reagents Business) headquartered?

    NeoClone (Antibody Reagents Business) is headquartered in WI.

  • What industry is NeoClone (Antibody Reagents Business) in?

    NeoClone (Antibody Reagents Business)’s primary industry is Discovery Tools (Healthcare).

  • Is NeoClone (Antibody Reagents Business) a private or public company?

    NeoClone (Antibody Reagents Business) is a Private company.

  • What is NeoClone (Antibody Reagents Business)’s current revenue?

    The current revenue for NeoClone (Antibody Reagents Business) is .

  • Who are NeoClone (Antibody Reagents Business)’s investors?

    NeoClone has invested in NeoClone (Antibody Reagents Business).

  • When was NeoClone (Antibody Reagents Business) acquired?

    NeoClone (Antibody Reagents Business) was acquired on 01-Oct-2014.

  • Who acquired NeoClone (Antibody Reagents Business)?

    NeoClone (Antibody Reagents Business) was acquired by BioLegend.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process